Prediction of Effective Drug Combinations by Chemical Interaction, Protein Interaction and Target Enrichment of KEGG Pathways

Drug combinatorial therapy could be more effective in treating some complex diseases than single agents due to better efficacy and reduced side effects. Although some drug combinations are being used, their underlying molecular mechanisms are still poorly understood. Therefore, it is of great interest to deduce a novel drug combination by their molecular mechanisms in a robust and rigorous way. This paper attempts to predict effective drug combinations by a combined consideration of: (1) chemical interaction between drugs, (2) protein interactions between drugs' targets, and (3) target enrichment of KEGG pathways. A benchmark dataset was constructed, consisting of 121 confirmed effective combinations and 605 random combinations. Each drug combination was represented by 465 features derived from the aforementioned three properties. Some feature selection techniques, including Minimum Redundancy Maximum Relevance and Incremental Feature Selection, were adopted to extract the key features. Random forest model was built with its performance evaluated by 5-fold cross-validation. As a result, 55 key features providing the best prediction result were selected. These important features may help to gain insights into the mechanisms of drug combinations, and the proposed prediction model could become a useful tool for screening possible drug combinations.

[1]  中尾 光輝,et al.  KEGG(Kyoto Encyclopedia of Genes and Genomes)〔和文〕 (特集 ゲノム医学の現在と未来--基礎と臨床) -- (データベース) , 2000 .

[2]  Lei Chen,et al.  Prediction of human genes' regulatory functions based on proteinprotein interaction network. , 2012, Protein and peptide letters.

[3]  George W. Yip,et al.  Therapeutic value of glycosaminoglycans in cancer , 2006, Molecular Cancer Therapeutics.

[4]  Pierre Acklin,et al.  Similarity Metrics for Ligands Reflecting the Similarity of the Target Proteins , 2003, J. Chem. Inf. Comput. Sci..

[5]  X. Chen,et al.  TTD: Therapeutic Target Database , 2002, Nucleic Acids Res..

[6]  Chin Yee Liew,et al.  QSAR classification of metabolic activation of chemicals into covalently reactive species , 2012, Molecular Diversity.

[7]  H. Holmsen Significance of testing platelet functions in vitro , 1994, European journal of clinical investigation.

[8]  Kuo-Chen Chou,et al.  Deciphering the effects of gene deletion on yeast longevity using network and machine learning approaches. , 2012, Biochimie.

[9]  Vinhthuy T. Phan,et al.  Chemical genomics of cancer chemopreventive dithiolethiones , 2009, Carcinogenesis.

[10]  Kuo-Chen Chou,et al.  Predicting the network of substrate-enzyme-product triads by combining compound similarity and functional domain composition , 2010, BMC Bioinformatics.

[11]  Susumu Goto,et al.  KEGG for representation and analysis of molecular networks involving diseases and drugs , 2009, Nucleic Acids Res..

[12]  Torsten Seemann,et al.  Evolution of Multidrug Resistance during Staphylococcus aureus Infection Involves Mutation of the Essential Two Component Regulator WalKR , 2011, PLoS pathogens.

[13]  Yu-Dong Cai,et al.  Prediction of Deleterious Non-Synonymous SNPs Based on Protein Interaction Network and Hybrid Properties , 2010, PloS one.

[14]  Xing-Ming Zhao,et al.  The drug cocktail network , 2012, BMC Systems Biology.

[15]  C. Ding,et al.  Gene selection algorithm by combining reliefF and mRMR , 2007, 2007 IEEE 7th International Symposium on BioInformatics and BioEngineering.

[16]  R. Sun,et al.  Closed-loop control of cellular functions using combinatory drugs guided by a stochastic search algorithm , 2008, Proceedings of the National Academy of Sciences.

[17]  Fuhui Long,et al.  Feature selection based on mutual information criteria of max-dependency, max-relevance, and min-redundancy , 2003, IEEE Transactions on Pattern Analysis and Machine Intelligence.

[18]  H. Bischoff Pharmacology of α-glucosidase inhibition , 1994 .

[19]  Peer Bork,et al.  Extraction of regulatory gene/protein networks from Medline , 2006, Bioinform..

[20]  David Allard,et al.  Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer , 2009, Science.

[21]  K. Chou,et al.  Predicting Anatomical Therapeutic Chemical (ATC) Classification of Drugs by Integrating Chemical-Chemical Interactions and Similarities , 2012, PloS one.

[22]  Leo Breiman,et al.  Random Forests , 2001, Machine Learning.

[23]  Xing-Ming Zhao,et al.  Prediction of Drug Combinations by Integrating Molecular and Pharmacological Data , 2011, PLoS Comput. Biol..

[24]  H. Gutmann,et al.  Primary porcine proximal tubular cells as a model for transepithelial drug transport in human kidney. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[25]  H. Yee,et al.  A Review of the Safety and Efficacy of Acarbose in Diabetes Mellitus , 1996, Pharmacotherapy.

[26]  C. Steinbeck,et al.  Recent developments of the chemistry development kit (CDK) - an open-source java library for chemo- and bioinformatics. , 2006, Current pharmaceutical design.

[27]  Christian von Mering,et al.  STRING 8—a global view on proteins and their functional interactions in 630 organisms , 2008, Nucleic Acids Res..

[28]  J. Lehár,et al.  Systematic discovery of multicomponent therapeutics , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[29]  W. Eanes,et al.  Direct Evidence That Genetic Variation in Glycerol-3-Phosphate and Malate Dehydrogenase Genes (Gpdh and Mdh1) Affects Adult Ethanol Tolerance in Drosophila melanogaster , 2009, Genetics.

[30]  M. Venkatesh,et al.  Generic antibiotic industries: Challenges and implied strategies with regulatory perspectives , 2011, Journal of pharmacy & bioallied sciences.

[31]  Tongliang Zhang,et al.  Using pseudo amino acid composition and binary-tree support vector machines to predict protein structural classes , 2007, Amino Acids.

[32]  M. Ouellette,et al.  Drug Uptake and Modulation of Drug Resistance in Leishmania by an Aquaglyceroporin* , 2004, Journal of Biological Chemistry.

[33]  Michael J. Keiser,et al.  Predicting new molecular targets for known drugs , 2009, Nature.

[34]  Yoshihiro Yamanishi,et al.  Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework , 2010, Bioinform..

[35]  Ron Kohavi,et al.  A Study of Cross-Validation and Bootstrap for Accuracy Estimation and Model Selection , 1995, IJCAI.

[36]  Duane D. Miller,et al.  Micellar Delivery of Bicalutamide and Embelin for Treating Prostate Cancer , 2009, Pharmaceutical Research.

[37]  P. Bork,et al.  Literature mining for the biologist: from information retrieval to biological discovery , 2006, Nature Reviews Genetics.

[38]  Xing-Ming Zhao,et al.  A systems biology approach to identify effective cocktail drugs , 2010, BMC Systems Biology.

[39]  R. Blaheta,et al.  Molecular targeting of prostate cancer cells by a triple drug combination down-regulates integrin driven adhesion processes, delays cell cycle progression and interferes with the cdk-cyclin axis , 2011, BMC Cancer.

[40]  J. Verweij,et al.  Multiple targeted tyrosine kinase inhibition in the clinic: all for one or one for all? , 2006, European journal of cancer.

[41]  F. Leroux,et al.  Inhibitors of steroidal cytochrome p450 enzymes as targets for drug development. , 2007, Recent patents on anti-cancer drug discovery.

[42]  Xiaohua Ma,et al.  Mechanisms of drug combinations: interaction and network perspectives , 2009, Nature Reviews Drug Discovery.

[43]  Claus Lundegaard,et al.  NetTurnP – Neural Network Prediction of Beta-turns by Use of Evolutionary Information and Predicted Protein Sequence Features , 2010, PloS one.

[44]  J. T. Sanderson,et al.  The steroid hormone biosynthesis pathway as a target for endocrine-disrupting chemicals. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[45]  A. Balmain,et al.  How many mutations are required for tumorigenesis? implications from human cancer data , 1993 .

[46]  P. Bork,et al.  Drug Target Identification Using Side-Effect Similarity , 2008, Science.

[47]  Kuo-Chen Chou,et al.  Predicting Biological Functions of Compounds Based on Chemical-Chemical Interactions , 2011, PloS one.

[48]  Leming Shi,et al.  Identifying Unexpected Therapeutic Targets via Chemical-Protein Interactome , 2010, PloS one.

[49]  N. Zisapel,et al.  A novel decoy that interrupts G93A-superoxide dismutase gain of interaction with malate dehydrogenase improves survival in an amyotrophic lateral sclerosis cell model. , 2009, Journal of medicinal chemistry.

[50]  K. Chou,et al.  Predicting Drug-Target Interaction Networks Based on Functional Groups and Biological Features , 2010, PloS one.

[51]  Y. Martin,et al.  Do structurally similar molecules have similar biological activity? , 2002, Journal of medicinal chemistry.

[52]  Kuo-Chen Chou,et al.  Predicting Functions of Proteins in Mouse Based on Weighted Protein-Protein Interaction Network and Protein Hybrid Properties , 2011, PloS one.

[53]  B. Aggarwal,et al.  Models for prevention and treatment of cancer: problems vs promises. , 2009, Biochemical pharmacology.

[54]  B. Matthews Comparison of the predicted and observed secondary structure of T4 phage lysozyme. , 1975, Biochimica et biophysica acta.

[55]  Zhirong Sun,et al.  CTKPred: an SVM-based method for the prediction and classification of the cytokine superfamily. , 2005, Protein engineering, design & selection : PEDS.

[56]  Ian Witten,et al.  Data Mining , 2000 .

[57]  J. Ioannidis,et al.  Most meta-analyses of drug interventions have narrow scopes and many focus on specific agents. , 2013, Journal of clinical epidemiology.

[58]  John C Ashton,et al.  Drug combination studies and their synergy quantification using the Chou-Talalay method--letter. , 2015, Cancer research.

[59]  Tom Fawcett,et al.  An introduction to ROC analysis , 2006, Pattern Recognit. Lett..

[60]  Lei Chen,et al.  Prediction of Metabolic Pathway Using Graph Property, Chemical Functional Group and Chemical Structural Set , 2013 .

[61]  Gajendra P. S. Raghava,et al.  GPCRpred: an SVM-based method for prediction of families and subfamilies of G-protein coupled receptors , 2004, Nucleic Acids Res..

[62]  อนิรุธ สืบสิงห์,et al.  Data Mining Practical Machine Learning Tools and Techniques , 2014 .

[63]  Claudiu T. Supuran,et al.  Carbonic anhydrases: novel therapeutic applications for inhibitors and activators , 2008, Nature Reviews Drug Discovery.

[64]  Pierre Baldi,et al.  Assessing the accuracy of prediction algorithms for classification: an overview , 2000, Bioinform..

[65]  Xue-jun Li,et al.  [Differential protein analysis in rat renal proximal tubule epithelial cells in response to acetazolamide and its relation with the inhibition of AQP1]. , 2003, Yao xue xue bao = Acta pharmaceutica Sinica.

[66]  Christian von Mering,et al.  STITCH: interaction networks of chemicals and proteins , 2007, Nucleic Acids Res..

[67]  John B. O. Mitchell The Relationship between the Sequence Identities of Alpha Helical Proteins in the PDB and the Molecular Similarities of Their Ligands , 2001, J. Chem. Inf. Comput. Sci..

[68]  D Hare,et al.  The Orange Book: the Food and Drug Administration's advice on therapeutic equivalence. , 1990, American pharmacy.

[69]  A. Esmaeili,et al.  Prediction of GABAA receptor proteins using the concept of Chou's pseudo-amino acid composition and support vector machine. , 2011, Journal of theoretical biology.

[70]  David S. Wishart,et al.  DrugBank: a comprehensive resource for in silico drug discovery and exploration , 2005, Nucleic Acids Res..

[71]  Blaise Lippa,et al.  The Hedgehog signaling pathway as a target for anticancer drug discovery. , 2005, Current topics in medicinal chemistry.

[72]  T. Chou Drug combination studies and their synergy quantification using the Chou-Talalay method. , 2010, Cancer research.

[73]  J. Carazo,et al.  GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists , 2007, Genome Biology.

[74]  J. Lehár,et al.  Multi-target therapeutics: when the whole is greater than the sum of the parts. , 2007, Drug discovery today.

[75]  John M. Barnard,et al.  Chemical Similarity Searching , 1998, J. Chem. Inf. Comput. Sci..

[76]  Xin Chen,et al.  DCDB: Drug combination database , 2010, Bioinform..

[77]  R. Madhubala,et al.  Role of aquaglyceroporin (AQP1) gene and drug uptake in antimony-resistant clinical isolates of Leishmania donovani. , 2008, The American journal of tropical medicine and hygiene.

[78]  T. West,et al.  Staphylococcus aureus disease and drug resistance in resource-limited countries in south and east Asia. , 2009, The Lancet. Infectious diseases.

[79]  Susan E. Abbatiello,et al.  Erratum: Synergistic drug combinations tend to improve therapeutically relevant selectivity , 2009, Nature Biotechnology.

[80]  P. Bork,et al.  Network Neighbors of Drug Targets Contribute to Drug Side-Effect Similarity , 2011, PloS one.

[81]  Linda J. Broadbelt,et al.  In silico feasibility of novel biodegradation pathways for 1,2,4-trichlorobenzene , 2010, BMC Systems Biology.